MR
Manjunatha Reddy Mardi
About Manjunatha Reddy Mardi
Data last updated:
Manjunatha Reddy Mardi was a Director at Dhatri Communications Private Limited (2006–2009), Director at Dhaatri Herbals Private Limited (from 2007) and Director at Sista Biosciences Private Limited (from 2008), and held 6 more directorships. The companies operate in Media and Publishing.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 22 Feb 2006 | 2006 | ₹3.74 Cr (FY 2025) | Active | |
| Director | 07 Sep 2007 | 2007 | Strike Off | ||
| Director | 27 Nov 2008 | 2008 | Strike Off | ||
| Director | 24 Jul 2007 | 2007 | Strike Off | ||
| Director | 11 May 2007 | 2007 | Strike Off | ||
| Director | 02 Apr 2007 | 2007 | Strike Off | ||
| Director | 20 Jan 2007 | 2007 | Strike Off | ||
| Director | 06 Jun 2005 | 2005 | Strike Off | ||
| Director | 28 Nov 2008 | 2008 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Manjunatha Reddy Mardi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manjunatha Reddy Mardi
Manjunatha Reddy Mardi was first appointed on 06 Jun 2005 as Director at Dhaatri Constructions Private Limited. The most recent appointment on record is 28 Nov 2008 at Sista Herbals Private Limited.
Manjunatha Reddy Mardi held 9 earlier board appointments: Dhatri Communications Private Limited (Director, 22 Feb 2006 to 27 Jun 2009); Dhaatri Herbals Private Limited (Director, from 07 Sep 2007); Sista Biosciences Private Limited (Director, from 27 Nov 2008); Dhaatri Laboratories Private Limited (Director, from 24 Jul 2007); Dhaatri Bio-Tech Private Limited (Director, from 11 May 2007); and 4 more.